How this company measures up on the fundamentals that matter
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading at $332 against a fair value of $491, a 33% discount. Passes all ethical screens. Ranks better than 88% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-31 | JIANG WEI | Director | 64 | — | |
| 2026-03-31 | KNIGHT HEATHER | Director | 68 | — | |
| 2026-03-16 | JIANG WEI | Director | 500 | $144,730 | |
| 2026-03-06 | FEARON RICHARD H | Director | 1,000 | $306,340 | |
| 2026-02-25 | ORNSKOV FLEMMING | Director | 336 | — | |
| 2026-02-25 | CHAUBAL AMOL | Chief Financial Officer | 1,455 | — | |
| 2026-02-25 | BATRA UDIT | Chief Executive Officer | 5,165 | — | |
| 2026-02-25 | FRASER CLAIRE | Director | 358 | — | |
| 2026-02-25 | VERGNANO MARK P | Director | 23 | — | |
| 2026-02-25 | BRENNAN DANIEL J | Director | 23 | — |
Congressional trading disclosures involving this instrument
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 6 Apr2026 | Josh Gottheimer | Democrat | buy | 1K–15K |
| 24 Apr2026 | Scott Peters | Democrat | sell | 50K–100K |
| 2026-04-13 | Ro Khanna | Democrat | Sale | 1K–15K |
| 2026-04-06 | Josh Gottheimer | Democrat | Purchase | 1K–15K |
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15